Abstract:Background and Objectives: Bone marrow derived mesenchymal stem cells (MSCs) transplantation confers protection against adverse cardiac remodeling mainly through paracrine effects, however, it remains largely unknow whether autophagy is involved in the protection offered by MSCs therapy. In the present study, we used the mice myocardial infarction(MI)model to investigate whether and how MSCs modulates autophagy activity to protect the injured myocardium. Methods and Results: Using a well established methodology of MSCs therapy for treating myocardial infarction, we reproduced the data that MSCs can reduce myocardial apoptosis to improve cardiac function post-MI, which was closely associated with attenuated autophagy flux in cardiac tissue. To further investigate how MSCs modulate autophagic activity, we co-cultured MSCs with neonatal mice cardiomyocytes (NMCMs) to test whether NMCMs co-cultured with MSCs exhibited enhanced tolerance to hypoxia. We showed that NMCMs exposed to hypoxia had increased autophagic flux, co-culture with MSCs resulted in a decrease in autophagic flux which was associated with improved apoptosis. Interestingly, NMCMs exposed to hypoxia exhibited up-regulated levels of p53 and its downward target Bnip3 at both mRNA and protein levels. Importantly, NMCMs co-cultured with MSCs had decreased p53 and bnip3 expression levels, suggesting that MSCs protected hypoxic cardiomyocytes via modulating autophagic flux through suppressing p53/bnip3 pathways. Exosome has been considered as the major paracrine components of MSCs, therefore, we extracted the exosomes from MSCs and it displayed the similar effects with MSCs on the autophagy modulation. We found miR-125b was an important component of exosome, inhibition of miR-125b in exosome abolished the effect of autophagy modulation via p53/Bnip3 signal pathway. Conclusion: MSCs, can exert the paracrine effects via miR-125b containing exosomes to block p53/Bnip3 pathway and decrease the autophagic related cell death, thus conferring protection for the cardiomyocytes.

MSCs ameliorate hepatocellular apoptosis mediated by PINK1-dependent mitophagy in liver ischemia/reperfusion injury through AMPKα activation

Bone marrow mesenchymal stem cells ameliorate hepatic ischemia/reperfusion injuries via inactivation of the MEK/ERK signaling pathway in rats.

Modulating autophagy in mesenchymal stem cells effectively protects against hypoxia- or ischemia-induced injury

Mesenchymal Stem Cells Ameliorate Hepatic Ischemia/Reperfusion Injury via Inhibition of Neutrophil Recruitment

The hepato-protective effect of H2S-modified and non-modified mesenchymal stem cell exosomes on liver ischemia-reperfusion injury in mice: The role of MALAT1

SRT1720 Pretreatment Promotes Mitochondrial Biogenesis of Aged Human Mesenchymal Stem Cells and Improves Their Engraftment in Postinfarct Nonhuman Primate Hearts.

The mitochondria‒paraspeckle axis regulates the survival of transplanted stem cells under oxidative stress conditions

The Antiapoptotic Effect of Mesenchymal Stem Cell Transplantation on Ischemic Myocardium is Enhanced by Anoxic Preconditioning.

Heat Shock Protein 90 Stimulates Rat Mesenchymal Stem Cell Migration Via PI3K/Akt and ERK1/2 Pathways

High Density Lipoprotein Protects Mesenchymal Stem Cells from Oxidative Stress-Induced Apoptosis Via Activation of the PI3K/Akt Pathway and Suppression of Reactive Oxygen Species

Protective Paracrine Effect of Mesenchymal Stem Cells on Cardiomyocytes

Mesenchymal stem cells pretreatment protects against liver ischemia-reperfusion injury

Apoptosis of Bone Marrow Mesenchymal Stem Cells Caused by Hypoxia/reoxygenation Via Multiple Pathways.

Mesenchymal Stem Cells Ameliorate Lipid Metabolism Through Reducing Mitochondrial Damage of Hepatocytes in the Treatment of Post-Hepatectomy Liver Failure

Bone marrow mesenchymal stem cell-derived hepatocyte-like cell exosomes reduce hepatic ischemia/reperfusion injury by enhancing autophagy.

Exosomes Derived from Mesenchymal Stem Cells Rescue Myocardial Ischaemia/Reperfusion Injury by Inducing Cardiomyocyte Autophagy Via AMPK and Akt Pathways.

Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells Attenuate Hepatic Ischemia-Reperfusion Injury by Suppressing Oxidative Stress and Inhibiting Apoptosis in Rats

BM‑MSCs Protect Against Liver Ischemia/reperfusion Injury Via HO‑1 Mediated Autophagy.

Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusion-induced lung injury

Abstract 21308: Mesenchymal Stem Cells Driven by Exosomal Mir-125b Protect Myocardial Infarction via P53-Mediated Autophagy Signalling

Bone Marrow-Derived Mesenchymal Stem Cells Enhance Autophagy Via PI3K/AKT Signalling to Reduce the Severity of Ischaemia/reperfusion-Induced Lung Injury